Some Maryland colleges and universities are supporting the state’s population of federal workers who have been displaced amid ...

South Korea’s LigaChem Biosciences has signed two antibody licensing agreements with US biotech NovaRock Biotherapeutics, reports Korea Biomedical Review.

Kite, unit today presented the latest results that demonstrate a 79% overall response rate (ORR) and 74% overall survival (OS ...

During Wednesday's trading session, shares of a pharmaceutical company involved in manufacturing and selling tablets, ...

Gilead Sciences’ Kite Pharma will sell its stake in China’s Fosun Kite Biotechnology nearly eight years after forming the 50-50 cell-therapy-focused joint venture with Fosun Pharma.

In a letter sent to staff this week that was obtained by Fierce Biotech, Kite Pharma Executive Vice President Cindy Perettie previewed a “refreshed business strategy” that would better align ...

SHANGHAI , July 18, 2023 /PRNewswire/ -- The product of Fosun Kite Biotechnology Co., Ltd., jointly established by Shanghai Fosun Pharmaceutical (Group) Co., Ltd. and Kite Pharma of the United ...

Kite Pharma, Gilead’s cell therapy subsidiary, said on Tuesday it would buy Tmunity, a biotech that was co-founded by the CAR-T pioneer Carl June but largely went dark after two patients died in ...

(RTTNews) - Fosun Kite Biotechnology Co., Ltd., a joint venture between Kite and Shanghai Fosun Pharmaceutical Co., Ltd, has received approval from the China National Medical Products ...

SANTA MONICA, Calif.--(BUSINESS WIRE)--Kite, a Gilead Company, announced that Fosun Kite Biotechnology Co., Ltd., a joint venture between Kite and Shanghai Fosun Pharmaceutical (Group) Co., Ltd ...

Through its $12.9 billion biotech buy Kite Pharma, the Californian company has inked a new deal with an almost unknown Australian biotech: oNKo-innate. The purpose of the deal is for Gilead and ...

The big biotech announced the Kite deal prior to the market open on Monday, Aug. 27. By the end of the week, Gilead's market cap had jumped to over $109 billion. In the subsequent weeks ...